Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is anti-tumor necrosis factor therapy effective in reducing uveitis flares in patients with spondyloarthropathies?

Nature Clinical Practice Rheumatology volume 3, pages 376–377 (2007)Cite this article

boxed-textGuignard S et al. (2006) Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study. Ann Rheum Dis 65: 1631–1634

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Levy-Clarke G and Nussenblatt R (2006) Does anti-TNF therapy decrease the incidence of anterior uveitis in patients with ankylosing spondylitis? Nat Clin Pract Rheumatol 2: 72–73

    Article  CAS  Google Scholar 

  2. El-Shabrawi Y and Hermann J (2002) Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis. Ophthalmology 109: 2342–2346

    Article  Google Scholar 

  3. Fries W et al. (2002) Treatment of acute uveitis associated with Crohn's disease and sacroileitis with infliximab. Am J Gastroenterol 97: 499–500

    Article  Google Scholar 

  4. Monnet D et al. (2004) Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology 111: 802–809

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. G Levy-Clarke is the Director of the Uveitis and Ocular Immunology Fellowship, G Reed is a statistician and Chief of the Biometry Branch, and R Nussenblatt is the Chief of the Laboratory of Immunology, all at the National Eye Institute, NIH, Bethesda, MD, USA.,

    Grace Levy-Clarke, George Reed & Robert Nussenblatt

Authors
  1. Grace Levy-Clarke
    View author publications

    Search author on:PubMed Google Scholar

  2. George Reed
    View author publications

    Search author on:PubMed Google Scholar

  3. Robert Nussenblatt
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Grace Levy-Clarke.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levy-Clarke, G., Reed, G. & Nussenblatt, R. Is anti-tumor necrosis factor therapy effective in reducing uveitis flares in patients with spondyloarthropathies?. Nat Rev Rheumatol 3, 376–377 (2007). https://doi.org/10.1038/ncprheum0512

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/ncprheum0512

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing